Posted on 10/30/20
Novavax Sells 60 Million Doses of Its Coronavirus Vaccine to the U.K. Government
In a Securities and Exchange Commission filing on Wednesday, Novavax (NASDAQ:NVAX) disclosed that the U.K. government had agreed to purchase 60 million doses of NVX-CoV2372, its . . .
Posted on 10/30/20
Teladoc Crushes Q3 Estimates
A breakout stock of the coronavirus era, Teladoc Health (NYSE:TDOC) delivered a third quarter that trounced analyst estimates.The period saw the telemedicine services specialist book just . . .
Posted on 10/30/20
Teladoc and Livongo Health Shareholders Approve the Companies' Merger
Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO) investors, in separate special shareholder meetings, overwhelmingly voted in favor of the merger of the two companies. Teladoc revealed . . .
Posted on 10/30/20
Alnylam Named a Top Biopharma Employer by Science Magazine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that, for the second year in a row, Science magazine has named . . .
Posted on 10/29/20
Coronavirus Recap, Oct. 22 – 29: Cases and Hospitalizations Rise
Maryland reported 962 additional coronavirus cases on Thursday, the largest number reported in one day in nearly two months since the state saw its caseload rise . . .
Posted on 10/29/20
Insmed Reports Third Quarter 2020 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results . . .
Posted on 10/29/20
Curve Health Raises $6M Seed Round
Curve Health, a company that delivers connected senior care via a platform that combines telemedicine, smart billing, health information exchange, and predictive analytics
Posted on 10/29/20
Teladoc Health Merge with Livongo
PURCHASE, NY, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Teladoc Health (TDOC), the global leader in whole person virtual care, today announced that its shareholders have overwhelmingly . . .
Posted on 10/29/20
Molina Healthcare's (MOH) CEO Joe Zubretsky on Q3 2020 Results - Earnings Call Transcript
Molina Healthcare, Inc. (NYSE:MOH) Q3 2020 Earnings Conference Call October 29, 2020 8:00 AM ETCompany ParticipantsJulie Trudell – Senior Vice President of Investor RelationsJoe Zubretsky – . . .
Posted on 10/29/20
Scholar Rock Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a . . .
Posted on 10/29/20
Alexion Reports Third Quarter 2020 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the third quarter of 2020. Total revenues in the third quarter were $1,588.7 million, a 26 . . .
Posted on 10/29/20
Elpis Biopharmaceuticals Closes $30 Million Series A
Elpis Biopharmaceuticals today announced the closing of a $30 million Series A financing to propel solid tumor and hematological disease therapeutics through pre-clinical studies
Posted on 10/29/20
Charles River Laboratories Announces Third-Quarter 2020 Results
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2020. For the quarter, revenue was $743.3 million, . . .
Posted on 10/29/20
Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, . . .
Posted on 10/29/20
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced . . .
Posted on 10/29/20
Md. Medical Experts Challenged By Public Skepticism of COVID-19 Vaccine
As pharmaceutical companies race to get a COVID-19 vaccine on the market, Maryland lawmakers and policy experts have found themselves rushing to find ways to motivate . . .
Posted on 10/29/20
Lexicon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical Update
THE WOODLANDS, Texas, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended September 30, 2020 . . .
Posted on 10/29/20
Agenus R&D Update & Third Quarter Financial Report
LEXINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and . . .
Posted on 10/29/20
Thermo Fisher Scientific Extends Collaboration with Symphogen to Advance Biopharmaceutical Discovery and Development
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company, Servier, . . .
Posted on 10/29/20
Syneos Health Reports Third Quarter 2020 Results
MORRISVILLE, N.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization and a Contract Commercial Organization, . . .
Posted on 10/29/20
Arbutus to Report Third Quarter 2020 Financial Results and Provide Corporate Update
WARMINSTER, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with . . .
Posted on 10/29/20
Evelo Biosciences Reports Third Quarter 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting . . .
Posted on 10/29/20
Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update
PARSIPPANY, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported financial results . . .
Posted on 10/29/20
Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results
CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, . . .
Posted on 10/29/20
Centrexion Therapeutics Raises $40.5 Million
Centrexion Therapeutics Corporation, a biotechnology company focused on developing and commercializing non-opioid, non-addictive chronic pain drugs and in-licensing

